| Bioactivity | 1,19-Bis(2-butyloctyl) 10-[[3-(dimethylamino)propyl](1-oxononyl)amino]nonadecanedioate is an excipient for vaccines. 1,19-Bis(2-butyloctyl) 10-[[3-(dimethylamino)propyl](1-oxononyl)amino]nonadecanedioate can be used for the research of the development of COVID-19 vaccines and drug delivery for gene therapy[1]. | ||||||||||||
| Name | 1,19-Bis(2-butyloctyl) 10-[[3-(dimethylamino)propyl](1-oxononyl)amino]nonadecanedioate | ||||||||||||
| CAS | 2036272-50-9 | ||||||||||||
| Formula | C57H112N2O5 | ||||||||||||
| Molar Mass | 905.51 | ||||||||||||
| Appearance | Liquid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage | 
  | 
||||||||||||
| Reference | [1]. HEYES JAMES, et al. PEG LIPIDS AND LIPID NANOPARTICLES. WO/2022/133344. 2022. |